Clinical trial
Combination Chemotherapy Combined With Radiation Therapy in Treating Patients…
NCT00008047 · GERCOR - Multidisciplinary Oncology Cooperative Group, Other · Unknown status
Key facts
| NCT number | NCT00008047 |
|---|---|
| Title | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus |
| Official title | Multicentre Phase II Study Of Concomitant Radio-Chemotherapy Associating Continuous Infusion 5-FU With Hydroxyuree Via Bone Marrow With Or Without Paclitaxel In Treatment Of Inoperable Epidermoid Carcinoma Of Esophagus |
| Lead sponsor | GERCOR - Multidisciplinary Oncology Cooperative Group, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | fluorouracil, hydroxyurea, paclitaxel, conventional surgery, radiation therapy |
| Start date | Aug 1, 1999 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 9, 2009 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: